Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Jason GrebelyGregory J DoreFrederick L AlticeBrian ConwayAlain H LitwinBrianna L NortonOlav DalgardEdward J GaneOren ShiboletRonald G NahassAnne F LuetkemeyerCheng-Yuan PengDavid IserIsaias Noel GendranoMichelle M KellyPeggy HwangErnest Asante-AppiahBarbara A HaberEliav BarrMichael N RobertsonHeather PlattPublished in: Annals of internal medicine (2022)
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.